Lowering Drug Prices Under Medicare Will "Harm Patients," Lobbying Group Says in New Lawsuit

The group is suing to stop Medicare from being able to access lower drug prices.The Chamber of Commerce of the United States of America building facade is pictured in Washington, D.C., on October 20, 2017.Bill Clark / CQ Roll Call The U.S.'s largest lobbying group, the conservative U.S. Chamber of Commerce, has become the second prominent group to file a lawsuit to stop a plan for Medicare to be able to negotiate the prices for a handful of drugs, joining pharma giant Merck in alleging that the plan is unconstitutional.

Read at Truthout